XML 49 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Tables)
 9 Months Ended
Sep. 30, 2021
Stockholders Equity Note [Abstract]  
Summary of the Warrants A summary of the warrants is as follows:

 

 

Number of

shares

 

 

Exercise

price

 

 

Expiration

date

Dragasac Warrant

 

 

6,529,818

 

 

$

6.77

 

*

March 16, 2025

March 2020 Series B Warrants

 

 

13,281,386

 

 

$

7.53

 

 

March 16, 2025

Public Warrants

 

 

14,374,992

 

 

$

11.50

 

 

July 16, 2026

Sponsor Warrants

 

 

8,499,999

 

 

$

11.50

 

 

July 16, 2026

 

 

 

42,686,195

 

 

 

 

 

 

 

 

*        The exercise price is the lessor of $6.77 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.